Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 301 | CELC | CELCUITY INC | Healthcare | 3,695.0 | $387K | 0.09% | +1K | +42.7% | $104.62 | -21.0% |
| 302 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 5,510.0 | $385K | 0.09% | +526.0 | +10.6% | $69.81 | -4.5% |
| 303 | CSWC | CAPITAL SOUTHWEST CORP | Financial Services | 16,171.0 | $384K | 0.09% | -6K | -28.0% | $23.77 | +0.4% |
| 304 | — | MSC INCOME FUND INC | — | 33,217.0 | $384K | 0.09% | -7K | -16.8% | $11.57 | — |
| 305 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 27,086.0 | $383K | 0.09% | -13K | -33.0% | $14.15 | -2.4% |
| 306 | SVRA | SAVARA INC | Healthcare | 62,205.0 | $383K | 0.09% | +23K | +57.9% | $6.16 | -14.6% |
| 307 | COGT | COGENT BIOSCIENCES INC | Healthcare | 9,885.0 | $383K | 0.09% | +3K | +52.6% | $38.70 | -15.4% |
| 308 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 9,395.0 | $382K | 0.09% | -2K | -18.6% | $40.63 | +7.4% |
| 309 | TSLX | SIXTH STREET SPECIALTY LENDI | Financial Services | 22,230.0 | $382K | 0.09% | -4K | -16.5% | $17.17 | +4.0% |
| 310 | ALMS | ALUMIS INC | Healthcare | 13,549.0 | $381K | 0.09% | -10K | -42.9% | $28.14 | -70.1% |
| 311 | RXRX | RECURSION PHARMACEUTICALS IN | Healthcare | 103,872.0 | $381K | 0.09% | +41K | +64.9% | $3.67 | -11.7% |
| 312 | ALT | ALTIMMUNE INC | Healthcare | 125,363.0 | $381K | 0.09% | +74K | +142.3% | $3.04 | +6.2% |
| 313 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 6,281.0 | $379K | 0.09% | +93.0 | +1.5% | $60.36 | -6.8% |
| 314 | SLRC | SLR INVESTMENT CORP | Financial Services | 30,547.0 | $378K | 0.09% | -788.0 | -2.5% | $12.37 | -2.4% |
| 315 | IMNM | IMMUNOME INC | Healthcare | 17,802.0 | $377K | 0.09% | +4K | +27.8% | $21.19 | +13.0% |
| 316 | IMVT | IMMUNOVANT INC | Healthcare | 9,732.0 | $375K | 0.09% | -588.0 | -5.7% | $38.53 | -4.9% |
| 317 | KOD | KODIAK SCIENCES INC | Healthcare | 9,606.0 | $374K | 0.09% | -2K | -16.1% | $38.96 | -15.3% |
| 318 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 13,853.0 | $374K | 0.09% | +6K | +87.5% | $26.98 | +7.2% |
| 319 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 11,513.0 | $374K | 0.09% | NEW | — | $32.45 | +32.6% |
| 320 | — | FIRST TRACKS BIOTHERAPEUTICS | — | 18,549.0 | $373K | 0.09% | NEW | — | $20.12 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.2%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%